Which diabetes combo works best? new study aims to find out

NCT ID NCT06246799

Recruiting now Disease control Sponsor: The University of Texas Health Science Center at San Antonio Source: ClinicalTrials.gov ↗

First seen Mar 16, 2026 · Last updated Apr 30, 2026 · Updated 9 times

Summary

This study compares two different drug combinations for people recently diagnosed with type 2 diabetes. One group gets pioglitazone plus tirzepatide, the other gets metformin plus sitagliptin. The goal is to see which combo better lowers blood sugar and keeps it under control over time. About 256 adults aged 18-75 who were diagnosed within the last 5 years will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES (ADULT ONSET) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

UT Health Science Center
RECRUITING

San Antonio, Texas, 78229, United States
University Health System Texas Diabetic Institute
RECRUITING

San Antonio, Texas, 78207, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

TYPE 2 DIABETES (ADULT ONSET)